Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (308)	12/20/1998 1:55:00 PM
From: Biomaven	Read Replies (1) \| Respond to of 1073

OK, maybe I was just infected with the same holiday spirit shown by the House of Representatives yesterday. <G> So let's see if I can present the bull case for the third tier: 1. Tax loss selling is nearly over. 2. Some valuations are compelling, with some good stocks trading near book. 3. Long and medium term pipelines are still pretty thin at some of the big pharmas like MRK and the big bios like AMGN. 4. The bear attacks on the newly profitable second tier like AGPH and PGNS have been successfully repulsed. While these stocks were sick, there was little incentive to look further back in the development cycle. Now they are doing well and are no longer screaming bargains, people will surely start looking at the earlier stage companies as well. 5. For companies that have the financial strength to survive, good science will ultimately win out and produce some 10-baggers. Peter